PLCG2 and amyloidosis: From a therapeutic point of view, PLCG2-directed therapeutic approaches might, therefore, offer a novel opportunity to complement drugs directed at amyloid clearance or production by modulating the downstream effects of amyloid pathology mediated by microglia [12, 28, 51, 71].